Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 19;10(5):214-215.
doi: 10.1016/j.aace.2024.03.005. eCollection 2024 Sep-Oct.

Insulin-Induced Severe Lipohypertrophy

Samir S E Ahmed  1 , Mona Vahidi Rad  1 , Joseph Arguinchona  2 , Bithika Thompson  1
Affiliations

Insulin-Induced Severe Lipohypertrophy

Samir S E Ahmed et al. AACE Clin Case Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig
Fig
A, Photograph showing bilateral periumbilical severe lipohypertrophy more prominent over the left side (2) but also the right side (1) is significant and easily palpable. B, Freestyle Libre data showing time in range of 48% with 52% high readings on the initial visit. C, Photograph showing Improvement of the bilateral periumbilical lipohypertrophy. In A (2) the dark nodule is 2 times the vertical height of the umbilicus and this same nodule in C is about one-half the vertical length of the umbilicus.
See this image and copyright information in PMC

References

    1. Gentile S., Guarino G., Della Corte T., et al. Lipohypertrophy in elderly insulin-treated patients with type 2 diabetes. Diabetes Ther. 2021;12(1):107–119. - PMC - PubMed
    1. Blanco M., Hernández M.T., Strauss K.W., Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–453. - PubMed
    1. Al Ajlouni M., Abujbara M., Batieha A., Ajlouni K. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus. Int J Endocrinol Metab. 2015;13(2) - PMC - PubMed

LinkOut - more resources